Full coverage· Health· Updated
Israel Launches National Trial Using Psychedelics for PTSD
Israel's Ministry of Health will initiate its first national trial using MDMA and psilocybin to treat hundreds of PTSD patients. The three-year study aims to provide new options for those unresponsive to current therapies, especially following the surge in trauma cases since October 7th.
2 newsrooms · 1 language · since
Plus
What happened
- 01Israel's Ministry of Health will conduct its first national trial using MDMA and psilocybin for PTSD.
- 02The trial will involve hundreds of patients with moderate to severe chronic PTSD.
- 03It aims to offer new treatment options for those unresponsive to conventional therapies.
- 04Substances will be administered under strict medical supervision in clinical settings.
- 05The study is a response to the rise in PTSD cases since October 7th.
- 06Participants will not receive take-home prescriptions for the substances.
Treatments will be administered under strict medical supervision in clinics, with no take-home prescriptions to ensure safety and prevent misuse.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre1
- Right1
- HarediNone
- ArabNone
How it broke
See which of the 2 newsrooms broke it, and who waited
